ZFIN ID: ZDB-PUB-120125-28
Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics
Ding, Y., Sun, X., Redfield, M., Kushwaha, S., and Xu, X.
Date: 2012
Source: Cell cycle (Georgetown, Tex.)   11(3): 428-429 (Other)
Registered Authors: Ding, Yonghe, Sun, Xiaojing, Xu, Xiaolei
Keywords: none
MeSH Terms:
  • Animals
  • Cardiomyopathies/drug therapy*
  • Cardiomyopathies/genetics
  • Mutation
  • Protein Kinase Inhibitors/pharmacology
  • Protein Kinase Inhibitors/therapeutic use*
  • Signal Transduction/drug effects
  • Sirolimus/pharmacology
  • Sirolimus/therapeutic use*
  • TOR Serine-Threonine Kinases/antagonists & inhibitors*
  • TOR Serine-Threonine Kinases/genetics
  • TOR Serine-Threonine Kinases/metabolism
  • Zebrafish/genetics*
PubMed: 22262179 Full text @ Cell Cycle
Citation
Ding, Y., Sun, X., Redfield, M., Kushwaha, S., and Xu, X. (2012) Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics. Cell cycle (Georgetown, Tex.). 11(3):428-429.
ABSTRACT
Comment on: Ding Y, et al. Circ Res 2011; 109:658-69.
ADDITIONAL INFORMATION No data available
ERRATA and NOTES
Editorial of: Ding Y, et al. Circ Res 2011; 109; 658-669
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.